NanoVibronix, Inc. to Present at the Investor Summit on December 17th in Philadelphia

PHILADELPHIA, PA / ACCESSWIRE / December 10, 2019 / NanoVibronix, Inc. (NASDAQ:NAOV), will be presenting at this year’s Investor Summit on December 17th in Philadelphia.

The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail investors.

About NanoVibronix, Inc.

NanoVibronix Inc. is a medical device company that is focused on creating medical devices utilizing its proprietary low intensity acoustic technology. The company’s patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible materials surfaces. This unique development may be utilized for a variety of medical applications requiring low cost therapeutic ultrasound qualities.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company please email info@microcapconf.com.

To request complimentary investor registration: please visit our website at www.microcapconf.com.

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.microcapconf.com

Or, contact Ashley Allard at ashley@microcapconf.com

SOURCE: NanoVibronix, Inc

View source version on accesswire.com:
https://www.accesswire.com/569752/NanoVibronix-Inc-to-Present-at-the-Investor-Summit-on-December-17th-in-Philadelphia

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

37 minutes ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

37 minutes ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

37 minutes ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

37 minutes ago